Skip to content
A Push in Canada for a National Rare Disease Strategy episode artwork

Feb 10, 2016 23 min

A Push in Canada for a National Rare Disease Strategy

from RARECast

Only 60 percent of treatments for rare disorders make it into Canada and most get approved up to six years later than in the United States and Europe, according to the Canadian Organization for Rare Disorders. In an effort to change the rare disease landscape in Canada, CORD has released a multi-pronged rare disease strategy for the country. We spoke to Durhane Wong-Rieger, president and CEO of the Canadian Organization for Rare Disorders, about the need for a national strategy, the effort to pass a regulatory framework for orphan drugs, and what it will take to make a national strategy a reality.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

A Push in Canada for a National Rare Disease Strategy

0:00 23:32

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of RARECast?

This episode is 23 minutes long.

When was this RARECast episode published?

This episode was published on February 10, 2016.

Can I download this RARECast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.